| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |